Basilea Pharmaceutica AG (SWX:BSLN)

Basilea Pharmaceutica AG Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	577	501	423	546	485	574
Market Cap Growth	18.52%	18.52%	-22.52%	12.62%	-15.59%	14.12%
Enterprise Value	568	551	505	636	551	662
Last Close Price	47.60	41.35	35.30	45.80	40.92	53.15
PE Ratio	8.17	6.46	40.46	44.94	-	-
Forward PE	13.32	10.63	15.17	98.35	-	-
PS Ratio	2.76	2.40	2.68	3.69	3.27	4.50
PB Ratio	7.13	6.19	-42.28	-26.35	-8.27	-5.63
P/TBV Ratio	6.22	6.22	-	-	-	-
P/FCF Ratio	7.95	6.90	31.48	139.32	-	-
P/OCF Ratio	6.74	6.74	29.69	77.36	-	-
EV/Sales Ratio	2.73	2.64	3.20	4.31	3.72	5.19
EV/EBITDA Ratio	8.73	8.72	21.78	29.31	154.82	-
EV/EBIT Ratio	9.21	8.93	23.05	30.58	183.33	-
EV/FCF Ratio	7.82	7.58	37.59	162.43	-	-
Debt / Equity Ratio	1.38	1.38	-12.86	-9.03	-3.74	-2.37
Debt / EBITDA Ratio	1.71	1.71	5.05	7.76	41.61	-
Debt / FCF Ratio	1.54	1.54	9.57	47.76	-	-
Asset Turnover	0.97	0.97	0.80	0.63	0.62	0.57
Inventory Turnover	3.99	3.99	4.13	4.19	5.33	6.11
Quick Ratio	3.93	3.93	2.48	1.96	1.22	3.87
Current Ratio	4.85	4.85	3.20	2.34	1.38	4.46
Return on Equity (ROE)	218.58%	218.58%	-	-	-	-
Return on Assets (ROA)	17.89%	17.89%	6.95%	5.56%	0.79%	-5.93%
Return on Capital (ROIC)	24.78%	24.78%	9.61%	7.96%	1.25%	-10.88%
Return on Capital Employed (ROCE)	29.07%	29.07%	17.43%	14.26%	4.13%	-
Earnings Yield	13.44%	15.48%	2.47%	2.23%	-1.41%	-2.56%
FCF Yield	12.58%	14.50%	3.18%	0.72%	-6.73%	-9.75%
Buyback Yield / Dilution	-14.10%	-14.10%	-1.67%	-2.24%	-13.62%	4.41%
Total Shareholder Return	-14.10%	-14.10%	-1.67%	-2.24%	-13.62%	4.41%

Source: S&P Capital IQ. Standard template. Financial Sources.